Kyorin Pharmaceutical Co Ltd (4569) Stock Price & News

4569:TYO

Kyorin Pharmaceutical Co Ltd

¥1,076.00

+2.87%

(+30.00) 1D

Nov 12, 3:30:00 PM GMT+9 · JPY

All symbols

	Symbol	Price	Change	% Change

Last report

Nov 10, 2026

Fiscal period

Q2 2027

- / -

Revenue / Est. (JPY)

27.84B / -

Fiscal Q2 2027 earnings call

Waiting for the earnings call

At a glance

Insights from the latest news and reports

Previous reportsAll values in JPY

Loading Previous Earnings...

All values in JPY	Dec 2025	Mar 2026	Jun 2026	Sep 2026
Revenue	33.72B	33.80B	29.65B	27.84B
Cost of goods sold	19.09B	21.71B	17.48B	17.63B
Cost of revenue	19.09B	21.71B	17.48B	17.63B
Research and development expenses	-	12.06B	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	11.39B	1.07B	11.21B	10.86B
Operating expense	11.39B	13.13B	11.22B	10.86B
Total operating expenses	30.48B	34.84B	28.69B	28.49B
Operating income	3.24B	-1.04B	964.00M	-658.00M
Other non operating income	12.00M	13.00M	15.00M	7.00M
EBT including unusual items	3.49B	-1.07B	1.19B	-3.09B
EBT excluding unusual items	3.51B	-1.07B	1.24B	-551.00M
Income tax expense	869.00M	-402.00M	363.00M	-696.00M
Effective tax rate	24.87%	37.47%	30.58%	22.55%
Other operating expenses	-	-	-	-
Net income	2.62B	-671.00M	824.00M	-2.39B
Net profit margin	7.78%	-1.99%	2.78%	-8.59%
Earnings per share	-	-	-	-
Interest and investment income	235.00M	12.00M	288.00M	57.00M
Interest expense	-59.00M	-70.00M	-59.00M	-60.00M
Net interest expenses	176.00M	-58.00M	229.00M	-3.00M
Depreciation and amortization charges	3.00M	2.00M	2.00M	-2.00M
EBITDA	4.39B	121.75M	2.13B	507.75M
Gain or loss from assets sale	-	-	-	-

Finance